1-AM

CAS No. ——

1-AM( KRAS G12C inhibitor 1 AM )

Catalog No. M16990 CAS No. ——

A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-AM
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.
  • Description
    A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    KRAS G12C inhibitor 1 AM
  • Pathway
    MAPK/ERK Signaling
  • Target
    Ras
  • Recptor
    Ras
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    510.998
  • Molecular Formula
    C26H28ClFN6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    3-((4-(4-acryloylpiperazin-1-yl)-6-chloro-7-(2-fluorophenyl)quinazolin-2-yl)amino)-N,N-dimethylpropanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zeng M, et al. Cell Chem Biol. 2017 Aug 17;24(8):1005-1016.e3.
molnova catalog
related products
  • ZCL278

    A potent, cell-permeable Cdc42-specific small-molecule inhibitor (Kd=6.4 uM).

  • ADT-007

    ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.

  • ARS-1620

    ARS-1620 is a potent, specific and covalent KRAS G12C inhibitor.